Affimed NV (AFMD)
2.64
-0.08
(-2.94%)
USD |
NASDAQ |
Nov 21, 16:00
2.67
+0.03
(+1.14%)
After-Hours: 20:00
Affimed Debt to Equity Ratio: 0.469 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 0.469 |
| June 30, 2024 | 0.3286 |
| March 31, 2024 | 0.2656 |
| December 31, 2023 | 0.2102 |
| September 30, 2023 | 0.1775 |
| June 30, 2023 | 0.1509 |
| March 31, 2023 | 0.1301 |
| December 31, 2022 | 0.1152 |
| September 30, 2022 | 0.0993 |
| June 30, 2022 | 0.0927 |
| March 31, 2022 | 0.1512 |
| December 31, 2021 | 0.1298 |
| September 30, 2021 | 0.076 |
| June 30, 2021 | 0.0671 |
| March 31, 2021 | 0.0596 |
| December 31, 2020 | 0.0045 |
| September 30, 2020 | 0.0272 |
| June 30, 2020 | 0.0314 |
| March 31, 2020 | 0.0531 |
| December 31, 2019 | 0.0616 |
| September 30, 2019 | 0.1466 |
| June 30, 2019 | 0.118 |
| Date | Value |
|---|---|
| March 31, 2019 | 0.0947 |
| December 31, 2018 | 0.1189 |
| September 30, 2018 | 0.1486 |
| June 30, 2018 | 0.1262 |
| March 31, 2018 | 0.121 |
| December 31, 2017 | 0.227 |
| September 30, 2017 | 0.2124 |
| June 30, 2017 | 0.1753 |
| March 31, 2017 | 0.0985 |
| December 31, 2016 | 0.1184 |
| September 30, 2016 | 0.0844 |
| June 30, 2016 | 0.0814 |
| March 31, 2016 | 0.0741 |
| December 31, 2015 | 0.068 |
| September 30, 2015 | 0.0814 |
| June 30, 2015 | 0.0719 |
| March 31, 2015 | 0.1471 |
| December 31, 2014 | 0.1225 |
| September 30, 2014 | 0.1006 |
| June 30, 2014 | -0.0508 |
| March 31, 2014 | -0.0433 |
| December 31, 2013 | -0.0484 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
0.0045
Minimum
Dec 2020
0.469
Maximum
Sep 2024
0.135
Average
0.1072
Median
Debt to Equity Ratio Benchmarks
| InflaRx NV | 0.00 |
| BioNTech SE | 0.0127 |
| Immatics NV | 0.00 |
| CureVac NV | 0.00 |
| ATAI Life Sciences NV | 0.1561 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 44.63M |
| Total Liabilities (Quarterly) | 25.43M |
| Shareholders Equity (Quarterly) | 19.21M |
| Current Ratio | 1.931 |
| Net Debt Paydown Yield | 2.62% |